- Nachrichtendetail
-
05.04.2024 15:46:18 - dpa-AFX: *FDA APPROVES BRISTOL MYERS AND 2SEVENTY BIO'S ABECMA FOR TRIPLE-CLASS EXPOSED R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 42,230 | 24.06.24 22:00:44 | +0,300 | +0,72% | 42,100 | 42,330 | 41,260 | 41,930 |
